Dr. Pawan Seth is listed in the
Hoag Hospital Foundation and is on the Allen Diabetes Center Oversight Committee. Hoag Hospital has invested significantly in the development of the treatments for diabetes.
Dr. Pawan Seth, a highly prolific developer of controlled release technologies and was a developmental partner of Biovail. He is the author or co-author/inventor listed on over 60 U.S. Patent applications.
Dr. Seth has been involved in clinical trials and research & development of new therapeutics for human diseases based on cellular therapies for various types of diseases like critical limb ischemia and other ischemic conditions.
An FDA approved clinical trial for this condition fully funded by Dr. Seth.
Pawan Seth’s goals is to develop therapies for diseases such as peripheral arterial disease, osteoarthritis, neurodegenerative and coronary diseases, without effective drug or medical therapies. He intends to seek FDA approval for marketing these therapies and also provide these therapies to underdeveloped and developing nations through charitable foundations.
Dr. Pawan Seth, Ph. D. is involved in research & development of new therapeutics for diseases. The work is in cellular therapies for various diseases such a critical limb ischemia and other ischemic conditions.
Pawan Seth has given a great deal of time and money in this area because it offers hope for effective treatment for this devastating and often serious condition resulting in amputations.